Qualitative Analysis of Perceptions, Incentives, and Barriers to Partner Notification Among MSM/TW Recently Diagnosed with HIV/STI; Lima, Peru 2011.

<p>Qualitative Analysis of Perceptions, Incentives, and Barriers to Partner Notification Among MSM/TW Recently Diagnosed with HIV/STI; Lima, Peru 2011.</p

Characteristics of recent male or TGW partners among MSM and TGW recently diagnosed with HIV and/or STI; Lima, Peru 2011–2012.

<p>*Totals for all variables do not add up to 893 due to missing data.</p>†<p>Percentage calculated from n = 817, for the subset of partnerships analyzed in the bivariate and multivariable models.</p

Participant and Partner Characteristics Associated with Anticipated Partner Notification Among MSM/TW Recently Diagnosed with HIV and/or STD; Lima, Peru 2011.

<p>Participant and Partner Characteristics Associated with Anticipated Partner Notification Among MSM/TW Recently Diagnosed with HIV and/or STD; Lima, Peru 2011.</p

Characteristics Associated with Unprotected Anal Intercourse in Recent Partnerships of MSM and TGW Diagnosed with HIV and/or STI; Lima, Peru 2011–2012.

<p>Characteristics Associated with Unprotected Anal Intercourse in Recent Partnerships of MSM and TGW Diagnosed with HIV and/or STI; Lima, Peru 2011–2012.</p

Incentives and Barriers to Partner Notification (By Partner Type) Among MSM/TW Recently Diagnosed with HIV and/or STD; Lima, Peru 2011.

<p>Incentives and Barriers to Partner Notification (By Partner Type) Among MSM/TW Recently Diagnosed with HIV and/or STD; Lima, Peru 2011.</p

Characteristics of MSM and TGW recently diagnosed with HIV and/or STI reporting exclusively male or TGW partners; Lima, Peru 2011–2012.

<p>*Totals for some variables do not add up to 339 due to missing data.</p>†<p>Report of HIV, syphilis, genital herpes and/or gonorrhea/chlamydia (GC/CT) within the previous 30 days.</p

Main intervention scenarios, proportional reduction in HIV prevalence across all MSM.

<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0102960#pone-0102960-g002" target="_blank">Figure 2a:</a> 25% uptake; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0102960#pone-0102960-g002" target="_blank">Figure 2b:</a> 50% uptake.</p

Main intervention scenarios, proportional reduction in incident HIV cases across all MSM relative to main baseline.

<p>The proportion of HIV-negative men being circumcised in each scenario is listed in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0102960#pone-0102960-t002" target="_blank">Table 2</a>. Theoretical confidence intervals are generated from the t-distribution based on the variation across 10 simulations, and shown as striped polygons. <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0102960#pone-0102960-g001" target="_blank">Figure 1a:</a> 25% uptake; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0102960#pone-0102960-g001" target="_blank">Figure 1b:</a> 50% uptake.</p

Cumulative cases averted per circumcision for various rates of role category switching (RCS), 80% insertive threshold / 25% uptake.

<p>Cumulative cases averted per circumcision for various rates of role category switching (RCS), 80% insertive threshold / 25% uptake.</p

Main intervention scenarios, cumulative cases averted per circumcision, without discounting.

<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0102960#pone-0102960-g003" target="_blank">Figure 3a:</a> 25% uptake; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0102960#pone-0102960-g003" target="_blank">Figure 3b:</a> 50% uptake.</p